This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

Official Name : Scott Gottlieb, M.D., Commissioner of Food and Drugs

No Significant Event

Official Name : Anna Abram, Deputy Commissioner for Policy, Planning, Legislation, and Analysis

No Significant Event

Official Name : Dara Corrigan, Acting Deputy Commissioner for Global Regulatory Operations and Policy

Event Date : 05/19/2017 - 05/19/2017
Location : Silver Spring, MD
Subject : FDA Bilateral Goals and Priorities with Indian Counterparts
FDA Participant/Group : MARY LOU VALDEZ; CARL SCIACCHITANO; DARA CORRIGAN;
Non FDA Participant/Group : R. K. Vats (Ministry of Health and Family Welfare, Government of India); Gyanendra Nath Singh (Ministry of Health and Family Welfare, Government of India and Indian Pharmacopoeia);

Official Name : Jim Sigg, Acting Deputy Commissioner for Operations

No Significant Event

Official Name : Stephen M. Ostroff, M.D., Deputy Commissioner for Foods and Veterinary Medicine

Event Date : 05/17/2017
Location : Washington, DC
Subject : Mosquito Control
FDA Participant/Group : N/A
Non FDA Participant/Group : The American Mosquito Control Association Meeting

Official Name : Melinda Plaisier, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name : Peter Lurie, M.D., M.P.H., Associate Commissioner for Policy and Planning

No Significant Event

Official Name : Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs

No Significant Event

Official Name : Jack Kalavritinos, Associate Commissioner for External Affairs

No Significant Event

Official Name : Janice Soreth, Associate Commissioner for Special Medical Programs

No Significant Event

Official Name : Luciana Borio, M.D., Acting Chief Scientist

Event Date : 05/17/2017 - 05/19/2017
Location : Geneva, Switzerland
Subject : World Health Organization Re: Options to Improve Regulatory Preparedness to Address Public Health Emergencies
FDA Participant/Group : ELIZABETH SADOVE; CARMEN MAHER;
Non FDA Participant/Group : N/A

Official Name : Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research

Event Date : 05/15/2017 - 05/15/2017
Location : Washington, DC.
Subject : Amyotrophic Lateral Sclerosis (ALS) Association National Advocacy Conference
FDA Participant/Group : N/A
Non FDA Participant/Group : N/A

Official Name : Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

No Significant Event

Official Name : Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date : 05/19/2017 - 05/19/2017
Location : Silver Spring, MD
Subject : 23andMe, Inc.
FDA Participant/Group : ALBERTO GUTIERREZ;
Non FDA Participant/Group : Sheila Walcoff(Goldbug Strategies LLC);

Official Name : Susan T. Mayne Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name : Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name : Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name : William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name : Elizabeth H. Dickinson, Esq., Chief Counsel

No Significant Event